JGP Global Gestao de Recursos’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,866
Closed -$307K 44
2025
Q4
$307K Sell
2,866
-387
-12% -$41.1K 0.18% 32
2025
Q3
$329K Sell
3,253
-571
-15% -$53K 0.19% 21
2025
Q2
$242K Hold
3,824
0.12% 38
2025
Q1
$203K Sell
3,824
-1,554
-29% -$86.2K 0.15% 30
2024
Q4
$301K Sell
5,378
-51,000
-90% -$2.82M 0.69% 31
2024
Q3
$2.95M Buy
56,378
+50,564
+870% +$2.42M 5.76% 3
2024
Q2
$239K Sell
5,814
-100,000
-95% -$3.99M 0.3% 30
2024
Q1
$4.58M Buy
105,814
+100,126
+1,760% +$4.38M 2.95% 8
2023
Q4
$261K Buy
+5,688
New +$179K 0.16% 39

Other funds holding RYTM

JGP Global Gestao de Recursos's RYTM Position: Q1 2026 in Review

JGP Global Gestao de Recursos sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2026, closing a stake of 2,866 shares — an estimated $307K sold.

JGP Global Gestao de Recursos first reported a position in RYTM in Q4 2023 and held it in 9 quarters. The position peaked at $4.58M in Q1 2024. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • JGP Global Gestao de Recursos reported no remaining Rhythm Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • JGP Global Gestao de Recursos sold 2,866 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $307K.
  • JGP Global Gestao de Recursos first reported a position in Rhythm Pharmaceuticals in Q4 2023 and held it in 9 quarters.
  • JGP Global Gestao de Recursos's Rhythm Pharmaceuticals position peaked at $4.58M in Q1 2024.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on JGP Global Gestao de Recursos's 13F filing for Q1 2026, filed 8 May 2026.